These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8807362)

  • 1. The role of anti-p53-autoantibodies in pancreatic disorders.
    Gansauge S; Gansauge F; Negri G; Galle P; Müller J; Nüssler AK; Poch B; Beger HG
    Int J Pancreatol; 1996 Jun; 19(3):171-8. PubMed ID: 8807362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of the anti-p53 antibody response in malignant and benign pancreatic disease.
    Marxsen J; Schmiegel W; Röder C; Harder R; Juhl H; Henne-Bruns D; Kremer B; Kalthoff H
    Br J Cancer; 1994 Nov; 70(5):1031-4. PubMed ID: 7947080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 autoantibodies in patients with pancreatitis and pancreatic carcinoma.
    Raedle J; Oremek G; Welker M; Roth WK; Caspary WF; Zeuzem S
    Pancreas; 1996 Oct; 13(3):241-6. PubMed ID: 8884844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic significance of p53 autoantibodies in serum of patients with breast carcinoma].
    Huober J; Sprenger H; Costa SD; Zentgraf H; Schmid H; Kaufmann M; Bastert G
    Zentralbl Gynakol; 1996; 118(10):560-4. PubMed ID: 8999710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating antibodies against p53 protein in patients with ovarian carcinoma. Correlation with clinicopathologic features and survival.
    Angelopoulou K; Rosen B; Stratis M; Yu H; Solomou M; Diamandis EP
    Cancer; 1996 Nov; 78(10):2146-52. PubMed ID: 8918407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and clinical significance of P53 pathway-associated proteins in pancreatic carcinoma].
    Yu GZ; Zhu MH; Chen Y; Ni CR; Li FM
    Ai Zheng; 2005 Nov; 24(11):1398-403. PubMed ID: 16552971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of p53 autoantibodies in sera from glioma patients.
    Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W
    Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of serum and ascitic p53 autoantibodies in epithelial ovarian carcinoma.
    Abendstein B; Marth C; Müller-Holzner E; Widschwendter M; Daxenbichler G; Zeimet AG
    Cancer; 2000 Mar; 88(6):1432-7. PubMed ID: 10717627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of p53 autoantibodies in the sera of patients with non-small-cell lung cancer.
    Mitsudomi T; Suzuki S; Yatabe Y; Nishio M; Kuwabara M; Gotoh K; Hatooka S; Shinoda M; Suyama M; Ogawa M; Takahashi T; Ariyoshi Y; Takahashi T
    J Natl Cancer Inst; 1998 Oct; 90(20):1563-8. PubMed ID: 9790550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 overexpression in lymph node metastases predicts clinical outcome in ductal pancreatic cancer.
    Campani D; Boggi U; Cecchetti D; Esposito I; Ceccarelli F; D'Antonio L; De Negri F; Mosca F; Bevilacqua G; Fornaciari G
    Pancreas; 1999 Jul; 19(1):26-32. PubMed ID: 10416688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implication of anti-p53 antibodies and p53-protein in pancreatic disease.
    Ohshio G; Suwa H; Imamura M
    Int J Gastrointest Cancer; 2002; 31(1-3):129-35. PubMed ID: 12622424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass.
    Vogl FD; Frey M; Kreienberg R; Runnebaum IB
    Br J Cancer; 2000 Nov; 83(10):1338-43. PubMed ID: 11044359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 autoantibodies in patients with primary ovarian cancer are associated with higher age, advanced stage and a higher proportion of p53-positive tumor cells.
    Vogl FD; Stickeler E; Weyermann M; Köhler T; Grill HJ; Negri G; Kreienberg R; Runnebaum IB
    Oncology; 1999 Nov; 57(4):324-9. PubMed ID: 10575320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 protein expression as prognostic factor in human pancreatic cancer.
    Sato Y; Nio Y; Song MM; Sumi S; Hirahara N; Minari Y; Tamura K
    Anticancer Res; 1997; 17(4A):2779-88. PubMed ID: 9252715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer.
    Anderson KS; Wong J; Vitonis A; Crum CP; Sluss PM; Labaer J; Cramer D
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):859-68. PubMed ID: 20200435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of p53 expression in human pancreatic carcinomas.
    Zhang SY; Ruggeri B; Agarwal P; Sorling AF; Obara T; Ura H; Namiki M; Klein-Szanto AJ
    Arch Pathol Lab Med; 1994 Feb; 118(2):150-4. PubMed ID: 8311654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Significance of Serum p53 Antibody in the Early Detection and Poor Prognosis of Gastric Cancer.
    Kunizaki M; Fukuda A; Wakata K; Tominaga T; Nonaka T; Miyazaki T; Matsumoto K; Sumida Y; Hidaka S; Yasutake T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2017 Apr; 37(4):1979-1984. PubMed ID: 28373470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of serum autoantibodies to tumor suppressor gene p53 with a new enzyme-linked immunosorbent assay in patients with ovarian cancer.
    Marx D; Frey M; Zentgraf H; Adelssen G; Schauer A; Kuhn W; Meden H
    Cancer Detect Prev; 2001; 25(2):117-22. PubMed ID: 11341346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock protein and p53 expression in head and neck squamous cell carcinoma.
    Gandour-Edwards R; Trock BJ; Gumerlock P; Donald PJ
    Otolaryngol Head Neck Surg; 1998 May; 118(5):610-5. PubMed ID: 9591858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma].
    Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ
    Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.